| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 778.5K | - | - | |
| Other | 425.0K | - | - | |
| Other | 282.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Dan Karlin | Chief Medical Officer | Sell10b5-1 | 6,871 | $5.98 | $41,088.58 | -2.0% | |
| Sep 25, 2024 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 4,430 | $5.98 | $26,491.40 | -2.4% | |
| Aug 23, 2024 | David W Gryska | Director | Buy | 3,500 | $5.98 | $20,930.00 | +25.3% | |
| Aug 20, 2024 | Robert Barrow | Chief Executive Officer | Buy | 1,000 | $6.22 | $6,215.00 | +0.2% | |
| Jun 25, 2024 | Mark Sullivan | Chief Legal Officer | Sell10b5-1 | 17,854 | $7.22 | $128,905.88 | -8.9% | |
| Jun 25, 2024 | Dan Karlin | Chief Medical Officer | Sell10b5-1 | 6,925 | $7.22 | $49,998.50 | -1.9% | |
| Jun 25, 2024 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 15,659 | $7.22 | $113,057.98 | -2.7% | |
| Mar 25, 2024 | Dan Karlin | Chief Medical Officer | Sell10b5-1 | 6,578 | $9.50 | $62,491.00 | -1.8% | |
| Mar 25, 2024 | Robert Barrow | Chief Executive Officer | Sell10b5-1 | 16,519 | $9.50 | $156,930.50 | -2.8% | |
| Dec 26, 2023 | Dan Karlin | Chief Medical Officer | Sell | 6,774 | $3.63 | $24,589.62 | -1.8% |